Tyche Bio-Medica Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 17-07-2024
- Paid Up Capital ₹ 3.07 Cr
as on 17-07-2024
- Company Age 33 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 10.98 Cr
as on 17-07-2024
- Revenue %
(FY 2022)
- Net Worth
- Total Assets %
(FY 2022)
About Tyche Bio-Medica
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.07 Cr.
The company currently has active open charges totaling ₹10.98 Cr.
Kirit Shandilya, Bhavesh Gandhi, and Varsha Shandilya serve as directors at the Company.
- CIN/LLPIN
U24100MH1991PLC061829
- Company No.
061829
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 May 1991
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Tyche Bio-Medica?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kirit Shandilya | Director | 27-May-1991 | Current |
Bhavesh Gandhi | Director | 01-Apr-2005 | Current |
Varsha Shandilya | Director | 27-May-1991 | Current |
Financial Performance of Tyche Bio-Medica.
Tyche Bio-Medica Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Tyche Bio-Medica?
In 2021, Tyche Bio-Medica had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Top Syringe Manufacturing Company Private LimitedActive 13 years 9 months
Bhavesh Gandhi is a mutual person
- Sunderji Chatrabhuj Estates Private LimitedActive 14 years 9 months
Bhavesh Gandhi is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Bank Of Baroda Creation Date: 29 Apr 1999 | ₹2.00 M | Open |
Bank Of Baroda Creation Date: 23 Dec 1998 | ₹1.25 Cr | Open |
Bank Of Baroda Creation Date: 22 Oct 1997 | ₹1.00 Cr | Open |
How Many Employees Work at Tyche Bio-Medica?
Unlock and access historical data on people associated with Tyche Bio-Medica, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tyche Bio-Medica, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tyche Bio-Medica's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.